Morphological Changes in the Carotid Artery Intima after Gastric Bypass for Morbid Obesity

被引:17
作者
Marchesi, Federico [1 ]
Giacosa, Roberto [2 ]
Reggiani, Valeria [1 ]
De Sario, Giuseppina [1 ]
Tartamella, Francesco [1 ]
Melani, Elisa [1 ]
Mita, Maria Teresa [1 ]
Cinieri, Francesco Giovanni [1 ]
Cecchini, Stefano [1 ]
Ricco', Matteo [3 ]
Salcuni, Pierfranco [4 ]
Roncoroni, Luigi [1 ]
机构
[1] Univ Parma, Sez Clin Chirurg Gen & Terapia Chirurg, Dipartimento Sci Chirurg, Via Gramsci 14, I-43100 Parma, Italy
[2] Dipartimento Med Interna, Clin Citta Parma, Piazzale Maestri 5, Parma, Italy
[3] UOPSAL, Azienda Prov & Serv Sanit Pa Trento, Viale Verona, I-38123 Trento, Italy
[4] Univ Parma, Dipartimento Sci Chirurg, Sez Chirurg Vas, Via Gramsci 14, I-43100 Parma, Italy
关键词
Obesity; Carotid intima-media thickness; Cardiovascular risk; Bariatric surgery; ISOLATED SYSTOLIC HYPERTENSION; CARDIOVASCULAR RISK-FACTORS; CORONARY-HEART-DISEASE; MEDIA THICKNESS; BARIATRIC SURGERY; WEIGHT-LOSS; ENDOTHELIAL DYSFUNCTION; WALL THICKNESS; ATHEROSCLEROSIS RISK; STRUCTURAL MARKERS;
D O I
10.1007/s11695-016-2279-9
中图分类号
R61 [外科手术学];
学科分类号
摘要
Carotid intima-media thickness (C-IMT) can be considered as an early marker of atherosclerosis, thus representing a reliable cardiovascular risk predictor. Bariatric surgery decreases the burden of cardiovascular disease in obese patients through complex mechanisms, of which weight loss is merely the most evident epiphenomenon. The aim of this study is to evaluate C-IMT variations in patients undergoing Roux-en-Y gastric bypass (RYGB) and possible correlations with biometric parameters and cardiovascular risk factors. Thirty patients undergoing RYGB for morbid obesity were enrolled for carotid artery B-mode ultrasound evaluation before surgery and at 1-, 3-, 6-, and 12-month follow-up; C-IMT was recorded at three levels (bulb, common, and internal carotid). At each one of the follow-ups, biometric and serohematic parameters were also collected. The 22 patients who completed the follow-up and were included in the study showed significant C-IMT reduction at all three levels at 12-month follow-up (p < 0.001). Along with a significant BMI reduction and diabetes/hypertension remission, we found a considerable decrease in total cholesterol (219 vs 164 mg/dl; p < 0.001) and uric acid (5.6 vs 4.5 mg/dl; p < 0.01) and a significant increase in HDL cholesterol (43.9vs59.2 mg/dl; p < 0.001). The data imply that the mean 10-year cardiovascular risk score drops by nearly 50 % (5.7 +/- 5.6 vs. 2.9 +/- 2.7 %, p < 0.001) according to Framingham cardiovascular risk stratification. RYGB is associated with significant decrease in C-IMT at 1 year. Pathophysiologic processes underlying such a variation, probably involving lipid and urate metabolism and their correlation with cardiovascular risk reduction should be confirmed by long-term prospective trials.
引用
收藏
页码:357 / 363
页数:7
相关论文
共 57 条
  • [11] The prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary artery disease
    Chan, SY
    Mancini, GBJ
    Kuramoto, L
    Schulzer, M
    Frohlich, J
    Ignaszewski, A
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (06) : 1037 - 1043
  • [12] Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
    Chobanian, AV
    Bakris, GL
    Black, HR
    Cushman, WC
    Green, LA
    Izzo, JL
    Jones, DW
    Materson, BJ
    Oparil, S
    Wright, JT
    Roccella, EJ
    [J]. HYPERTENSION, 2003, 42 (06) : 1206 - 1252
  • [13] Allopurinol and Nitric Oxide Activity in the Cerebral Circulation of Those With Diabetes
    Dawson, Jesse
    Quinn, Terry
    Harrow, Craig
    Lees, Kennedy R.
    Weir, Christopher J.
    Cleland, Stephen J.
    Walters, Matthew R.
    [J]. DIABETES CARE, 2009, 32 (01) : 135 - 137
  • [14] De Caterina R, 2000, Curr Opin Clin Nutr Metab Care, V3, P453, DOI 10.1097/00075197-200011000-00007
  • [15] Effect of long-term and high-dose allopurinol therapy on endothelial function in normotensive diabetic patients
    Dogan, Ali
    Yarlioglues, Mikail
    Kaya, Mehmet Gungor
    Karadag, Zakir
    Dogan, Serap
    Ardic, Idris
    Dogdu, Orhan
    Kilinc, Yusuf
    Zencir, Cemil
    Akpek, Mahmut
    Ozdogru, Ibrahim
    Oguzhan, Abdurrahman
    Kalay, Nihat
    [J]. BLOOD PRESSURE, 2011, 20 (03) : 182 - 187
  • [16] Engel S, 2003, NEW ENGL J MED, V348, P2294
  • [17] Uric acid and cardiovascular risk
    Feig, Daniel I.
    Kang, Duk-Hee
    Johnson, Richard J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (17) : 1811 - 1821
  • [18] Fried M, 2013, OBESITY FACTS, V6, P449, DOI [10.1007/s11695-013-1079-8, 10.1159/000355480]
  • [19] García G, 2013, NUTR HOSP, V28, P1102
  • [20] 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult-2009 recommendations
    Genest, Jacques
    McPherson, Ruth
    Frohlich, Jiri
    Anderson, Todd
    Campbell, Norm
    Carpentier, Andre
    Couture, Patrick
    Dufour, Robert
    Fodor, George
    Francis, Gordon A.
    Grover, Steven
    Gupta, Milan
    Hegele, Robert A.
    Lau, David C.
    Leiter, Lawrence
    Lewis, Gary F.
    Lonn, Eva
    Mancini, G. B. John
    Ng, Dominic
    Pearson, Glen J.
    Sniderman, Allan
    Stone, James A.
    Ur, Ehud
    [J]. CANADIAN JOURNAL OF CARDIOLOGY, 2009, 25 (10) : 567 - 579